USD 0.6
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 15.5 Million | 1.69 Billion | 3.05 Billion | 1.52 Billion | 1.37 Billion | 1.71 Billion |
Net Income | -7.6 Million | 13.5 Billion | 493.8 Million | 384.2 Million | 824.9 Million | 222.1 Million |
Depreciation & Amortization | 11.9 Million | 3.74 Million | 703.2 Million | 614.6 Million | 450.5 Million | 460.6 Million |
Deferred income taxes | -13.14 Million | - | - | - | - | - |
Stock-based compensation | 2.53 Million | 11.56 Million | 6.1 Million | 9.5 Million | 14.7 Million | - |
Change in working capital | 1.4 Million | -327.5 Million | -229.2 Million | 61.4 Million | -193 Million | -8.8 Million |
Other non-cash items | 1.3 Million | -11.47 Billion | 2.09 Billion | 467.8 Million | 295.8 Million | 1.04 Billion |
Investing Cash Flow | -79.1 Million | -458.6 Million | -1.41 Billion | -1.07 Billion | -106.5 Million | -1.05 Billion |
Investments in PPE | -100 Thousand | -293.1 Million | -1.32 Billion | -922.1 Million | -1.06 Billion | -1.06 Billion |
Acquisitions | -79 Million | -164.1 Million | -77.3 Million | -99.8 Million | 959 Million | - |
Investment purchases | -81.9 Million | - | - | - | -1.5 Million | - |
Sales/Maturities of investments | - | - | - | - | - | 9.3 Million |
Other Investing Activities | -1.00 | -1.4 Million | -11.6 Million | -57.9 Million | -3.7 Million | -1.3 Million |
Financing Cash Flow | 57.7 Million | -831.7 Million | -1.3 Billion | -456.2 Million | -1.25 Billion | -674.7 Million |
Debt repayment | -59 Million | -548.11 Million | -2.79 Billion | -79.67 Million | -623.6 Million | - |
Dividends payments | - | -277.4 Million | -401.86 Million | -258.7 Million | -317.45 Million | -133.84 Million |
Common Stock Repurchased | - | - | - | - | -1.51 Billion | -14.3 Million |
Common Stock Issuance | - | 56.3 Million | - | - | - | - |
Other Financing Activities | -1.43 Million | -599.9 Million | 1.94 Billion | -138 Million | 620.3 Million | -507.3 Million |
Accounts receivables | 1.54 Million | -339.54 Million | -229 Million | 94.2 Million | -140.3 Million | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | -8.1 Million | -7.2 Million | -4.2 Million | -2.8 Million |
Other working capital | 1.4 Million | 6.74 Million | -221.1 Million | 68.6 Million | -188.8 Million | -6 Million |
Cash at beginning of period | 26.9 Million | 452.1 Million | 82.5 Million | 85.3 Million | 66.8 Million | 71.4 Million |
Cash at end of period | 21.8 Million | 28.7 Million | 452.1 Million | 82.5 Million | 85.3 Million | 66.8 Million |
Capital Expenditure | -100 Thousand | -293.1 Million | -1.32 Billion | -922.1 Million | -1.06 Billion | -1.06 Billion |
Effect of forex changes on cash | 800 Thousand | 69.8 Million | 24.6 Million | 5.2 Million | -700 Thousand | 7.1 Million |
Net cash flow / Change in cash | -5.1 Million | -423.4 Million | 369.6 Million | -2.8 Million | 18.5 Million | -4.6 Million |
Free Cash Flow | 15.4 Million | 1.4 Billion | 1.73 Billion | 605.9 Million | 317.9 Million | 655 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 6.75 Million | -2.34 Million | 8.1 Million | -7.6 Million | -7.7 Million | -7.9 Million |
Depreciation & Amortization | 3.83 Million | 4 Million | 3.59 Million | 11.9 Million | 2.7 Million | 2.7 Million |
Deferred income taxes | -5.39 Million | -195.33 Thousand | -11.7 Million | - | -99.42 Thousand | -1141.19 |
Stock-based compensation | - | - | 772.79 Thousand | 2.53 Million | 422.87 Thousand | 763.85 Thousand |
Change in working capital | 2.28 Million | -879 Thousand | -607.32 Thousand | 1.4 Million | 4.1 Million | -3.7 Million |
Other non-cash items | -1.18 Million | 10.05 Million | 6.93 Million | 1.3 Million | 1.77 Million | 5.43 Million |
Investing Cash Flow | 45.94 Million | -1.85 Million | -20.57 Million | -79.1 Million | -14.5 Million | -28 Million |
Investments in PPE | -599.5 Thousand | - | -423.10 | -100 Thousand | -100 Thousand | - |
Acquisitions | -2.91 Million | -1.85 Million | 53.63 Million | -79 Million | -14.4 Million | -28 Million |
Investment purchases | - | - | -74.2 Million | - | - | - |
Sales/Maturities of investments | 49.45 Million | - | - | - | - | - |
Other Investing Activities | -600 Thousand | - | 0.10 | -1.00 | - | - |
Financing Cash Flow | -47.49 Million | -3.32 Million | 22.42 Million | 57.7 Million | 6.7 Million | 19.9 Million |
Debt repayment | -47.29 Million | -3.32 Million | -21.1 Million | -59 Million | -8.13 Million | -19.21 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -199.83 Thousand | -323.73 Thousand | 1.32 Million | -1.43 Million | 14.83 Million | 39.11 Million |
Accounts receivables | - | - | 1.54 Million | 1.54 Million | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 2.3 Million | -971.18 Thousand | -2.2 Million | - | 4.1 Million | -3.7 Million |
Cash at beginning of period | 18.69 Million | 21.7 Million | 19.74 Million | 26.9 Million | 28 Million | 36.9 Million |
Cash at end of period | 15.92 Million | 18.69 Million | 21.7 Million | 21.8 Million | 19.9 Million | 28 Million |
Capital Expenditure | -599.5 Thousand | - | -423.10 | -100 Thousand | -100 Thousand | - |
Effect of forex changes on cash | 200 Thousand | -500 Thousand | 900 Thousand | 800 Thousand | -1.5 Million | 1.9 Million |
Net cash flow / Change in cash | -2.77 Million | -3 Million | 1.95 Million | -5.1 Million | -8.1 Million | -8.9 Million |
Free Cash Flow | -1.97 Million | 2.63 Million | -858.94 Thousand | 15.4 Million | 1.1 Million | -2.7 Million |
SMARTFIN
UNM
DV8
ARTEMISMED
3199
8074